Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28966332 | 0.91 | HPGD (0.47) | KMT2AMAPTMEN1ALDH1A1HPGD | |
| SCHEMBL28966334 | 0.91 | HPGD (0.47) | KMT2AMAPTMEN1ALDH1A1HPGD | |
| SCHEMBL12988373 | 0.88 | KMT2A (0.44) | TSHRKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL11592383 | 0.86 | NPC1 (0.50) | TSHRKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL11592388 | 0.85 | MAPT (0.47) | TSHRKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL8760108 | 0.85 | MAPT (0.51) | TSHRKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL27468094 | 0.85 | MAPT (0.51) | TSHRKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL4876482 | 0.83 | ALDH1A1 (0.49) | TSHRKMT2AMAPTMEN1ALDH1A1 | |
| SCHEMBL4623730 | 0.83 | SMN1; SMN2 (0.49) | TSHRKMT2AMEN1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL21066864 | 0.83 | KMT2A (0.45) | TSHRKMT2AMAPTMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4556480-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | Fileclo Spolka Z Ograniczona Odpowiedzialnoscia (PL) | 2025-05-21 | — | — | EP | disclosed |
| US-20240294541-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | FILECLO SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2024-09-05 | — | — | US | disclosed |
| EP-4380939-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | Fileclo Spolka Z Ograniczona Odpowiedzialnoscia (PL) | 2024-06-12 | — | — | EP | disclosed |
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| WO-2023012323-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | FILECLO SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2023-02-09 | — | — | WO | disclosed |
| CN-115232030-A | Aryl urea compound and preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2022-10-25 | — | — | CN | disclosed |
| CN-114874143-A | Regulator containing pyrazole derivatives, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-113115588-A | Novel carbamate hydrolase for enzymatic decomposition of polyurethane | 科思创知识产权两合公司 | 2021-07-13 | — | — | CN | disclosed |
| WO-2014184071-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014184070-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| EP-0184291-A2 | Polyether antibiotic A80190 | ELI LILLY AND COMPANY (US) | 1986-06-11 | — | — | EP | disclosed |
| US-4582822-A | ANIMAL FEED ADDITIVES | ELI LILLY AND COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
| EP-0102680-B1 | SUBSTITUTED N-(2,4-DINITRO-6-(TRIFLUOROMETHYL)PHENYL)-NAPHTHALENAMINE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1986-03-05 | — | — | EP | disclosed |
| EP-0076059-B1 | ANTICOCCIDIAL COMBINATIONS | ELI LILLY AND COMPANY (US) | 1985-08-21 | — | — | EP | disclosed |
| EP-0102680-A1 | Substituted N-(2,4-dinitro-6-(trifluoromethyl)phenyl)-naphthalenamine derivatives | ELI LILLY AND COMPANY (US) | 1984-03-14 | — | — | EP | disclosed |
| EP-0076059-A1 | Anticoccidial combinations | ELI LILLY AND COMPANY (US) | 1983-04-06 | — | — | EP | disclosed |
| US-4366168-A | POLYETHER ANTIBIOTIC AND 2, 4-DINITRO N- 4-(POLYFLUOROALKOXY)PHENYL -6-(TRIBLUOROMETHYL) BENZENAMINE | ELI LILLY AND COMPANY (US) | 1982-12-28 | — | — | US | disclosed |
| US-4294925-A | FERMENTATION, AEROBIC PROCESSES | HOFFMANN-LA ROCHE INC. (US) | 1981-10-13 | — | — | US | disclosed |
| US-4263427-A | REACTING HYDROXYL WITH ISOCYANATE TO OBTAIN ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1981-04-21 | — | — | US | disclosed |
| US-3962416-A | Preserved nutrients and products | KATZEN SOL | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294541-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | MRPS22, MRPS27, DHPS | TSHR 4476/4885KMT2A 1660/4885MAPT 4251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.